Natural organic matter (NOM) can influence pharmaceutical adsorption onto granular activated carbon (GAC) by direct adsorption competition and pore blocking. However, in the literature there is limited information on which of these mechanisms is more important and how this is related to NOM and pharmaceutical properties. Adsorption batch experiments were carried out in ultrapure, waste-and surface water and fresh and NOM preloaded GAC was used.
INTRODUCTION
Trace concentrations of pharmaceuticals and personal care products (PPCP) have been detected in natural water sources in the U.S. and Europe (Ternes et al. 2002; Westerhoff et al. 2005; Zwiener 2007; Snyder 2008; Mompelat et al. 2009 ). The main pathway for PPCPs to enter surface water is via wastewater effluent, and PPCPs may potentially cause adverse ecological effects at the concentrations found in surface waters (Hernando et al. 2006) . When treating surface water to produce drinking water, various techniques can be applied to remove PPCPs, such as ozonation, activated carbon filtra-tion, chlorination or irradiation with UV (Ternes et al. 2002; Westerhoff et al. 2005; Snyder 2008) . Although it is unlikely that PPCPs pose significant threats to human health at the concentrations at which they are detected in finished drinking water (Snyder 2008) , drinking water companies aim to reduce PPCP concentrations even further out of precaution.
Activated carbon is widely used to remove organic micropollutants, and several researchers have investigated its efficacy for the removal of PPCP on fresh activated carbon in natural water (Ternes et al. 2002; Westerhoff et al. 2005; Redding et al. 2009 ). Pharmaceutical hydrophobicity and charge are recognised as important solute properties that influence their removal. The influence of preloading granular activated carbon (GAC) with natural organic matter (NOM) and/or co-adsorption with NOM was not investigated explicitly by these authors. NOM can reduce PPCP removal by the following mechanisms: (1) natural organic matter (NOM) competes for available adsorption surface area and adsorption sites, and (2) NOM blocks (micro)pores, which reduces the available surface area (Newcombe & Drikas 1997; Kilduff et al. 1998; Pelekani & Snoeyink 1999; Matsui et al. 2002) . Direct competition with larger NOM fractions is lower because of size exclusion within GAC grains (Worch 2008) .
NOM adsorption, and thus its ability to compete for available adsorption surface area, is influenced by charge interactions (Newcombe & Drikas 1997) . NOM is negatively charged at neutral pH, and electrostatic repulsion or attraction can occur between NOM and GAC. GAC surface charge depends on the quantity of acid and basic functional groups, and the pKa value at which these dissociate and protonate, respectively (Moreno-Castilla 2004) . When the amount of dissociated and protonated functional groups is equal, the net surface charge is zero. The pH value at which a net zero charge is obtained (pH pzc ) depends on the GAC type, and can vary between 3.4 and 8 (Newcombe & Drikas 1997; Bjelopavlic et al. 1999; Fairey et al. 2006) . Most GAC types presented by these authors have pH pzc values betweem 6.5 and 8, indicating that GAC surface can be slightly positively charged or negatively charged at neutral pH.
Electrostatic repulsion is less influential at lower pH values as the negative charge of NOM is reduced and the net surface charge of GAC becomes less negative, or becomes positive. A high ionic strength can reduce the effect of electrostatic repulsion or attraction (Newcombe & Drikas 1997; Fairey et al. 2006) . When a layer of NOM has been adsorbed on GAC, the surface becomes negatively charged due to NOM coverage, with increasing negative charge at higher NOM loading (Newcombe 1994) . This may promote electrostatic repulsion, reducing adsorption of NOM and anionic pharmaceuticals.
Although interaction mechanisms are proposed in the literature to explain the influence of NOM on pharmaceutical removal, it is not clear which of the interaction mechanisms is more dominant, how this is related to NOM and pharmaceutical characteristics, and how this changes when NOM has already adsorbed onto GAC. Insight into these relationships is required, however, to predict pharmaceutical removal in the presence of NOM a-priori. A-priori prediction models can be useful to determine if new pharmaceuticals are likely to be removed or not in an activated carbon filter, without requiring extensive field testing.
This study aimed to relate NOM composition (based on liquid chromatography with organic carbon detection (LC-OCD) analysis) and pharmaceutical hydrophobicity and charge to their removal. The second objective was to investigate the influence of NOM competition and pore blocking separately.
Adsorption experiments were carried out in ultrapure water and two natural water types containing different NOM mixtures. In order to separate NOM competition and pore blocking, the following configurations were investigated: Natural water, fresh GAC; mainly NOM competition is expected Ultrapure water, NOM preloaded GAC; NOM competition and pore blocking are expected Natural water, NOM preloaded GAC; stronger NOM competition and similar pore blocking are expected as in the experiment with ultrapure water Furthermore, the change in available adsorption surface area as a consequence of preloading was measured.
MATERIALS AND METHODS
Equilibrium batch experiments were conducted with an equilibrium time of 8 weeks. Three water matrices were used: buffered ultrapure water, treated surface water and treated wastewater. Whole GAC grains were used, either fresh or preloaded with NOM. All pharmaceuticals had an initial concentration of 2 mg/L. During the experiment, the samples were stored in a climate room at 121C and stirred continuously with a magnetic stirrer (LD-746, Labenco, Netherlands) at 84 rpm. For each adsorption isotherm determination, five GAC doses were used (from 6.7 to 88.9 mg/L) and a blank measurement was included. The blank solution was spiked with pharmaceuticals, but no GAC was dosed.
Surface water, wastewater and fresh and preloaded GAC were obtained from Waternet, watercycle company for Amsterdam and surrounding areas. The surface water originated from Weesperkarspel water treatment plant and was taken after coagulation, storage (about 100 days), filtration, ozonation and pellet softening. The wastewater originated from waste water treatment plant Horstermeer after primary sedimentation, activated sludge and secondary sedimentation. Both surface water and wastewater were filtered through a 1.2 mm polypropylene filter (Sartopure PP2 maxicap, Sartorius, Netherlands) and a 0.45 mm nylon filter (Polycap AS, Whatman, Netherlands) before use. The ultrapure water was generated on-site from tap water, using ion exchange and nanofiltration treatment. Ultrapure water samples were buffered with 1 mM NaH 2 PO 4 .H 2 O.
Twenty-one pharmaceuticals (see Table 1 ) were obtained from Sigma-Aldrich and were analytical grade. The pharmaceuticals were selected based on solute charge and were ordered in three charge groups: negatively charged, neutral and positively charged. The selected solutes have similar molecular weight, but varied in hydrophobicity. Hydrophobicity was expressed by log D. Log D is equivalent to log K ow (octanol-water partitioning coefficient), which is corrected for molecule dissociation/protonation according to Equations (1) and (2):
Bases : logD ¼ logK ow À logð1 þ 10 ðpKaÀpHÞ Þ ð 2Þ
All pharmaceuticals were dosed as a mixture. This may result in lower removal in ultrapure water as compared with single solute isotherms. In surface water and wastewater, mutual competition effects between pharmaceuticals are expected to be negligible; the TOC concentration in natural water is 2,500 times higher than the concentrations of the pharmaceuticals. Similarly, a high TOC to pharmaceutical ratio is expected when considering adsorption competition in NOM-preloaded GAC.
The various NOM fractions of the natural waters were quantified using LC-OCD. First they are separated based on size with liquid chromatography (LC), and then quantified with organic carbon detection (OCD), a procedure similar to regular TOC analyses. The NOM fraction that does not elute from the LC column after 200 minutes is identified as hydrophobic organic carbon (HOC). In addition, the specific UV adsorption (SUVA) at 254 nm was determined, which is a measure of the aromaticity of NOM.
Fresh and preloaded Norit GAC830 P granular activated carbon was used. Preloading was done using Weesperkarspel surface water or Horstermeer waste water effluent for at least 6 months. In order to use preloaded GAC with characteristics similar to field practice, the GAC was not dried before use. Both fresh and preloaded GAC was sieved wet and the fraction 0.6-0.71 mm was collected. After sieving, the required amount of GAC was weighed in its wet condition. When equilibrium was reached, the GAC was collected and dried at 1051C for 24 hours, after which its dry weight was determined.
GAC characterisation measurements were done by Norit (Amersfoort). Total available surface area on fresh and preloaded GAC was determined by nitrogen adsorption, and calculated as BET (Brunauer, Emmett, Teller) surface area. Micro-, meso-and macropore volumes were determined by nitrogen adsorption and calculated with the BJH method (Barrett, Joyner, Helena).
In addition to nitrogen adsorption, adsorption of iodine and methylene blue was measured on fresh and preloaded GAC. The adsorbed amounts of iodine and methylene blue are indications of the available micro pore and macro pore surface, respectively (Bestani et al. 2008) . Both measurements should be regarded as indicative. Iodine adsorption can be related to (Mianowski et al. 2007) , although there may still be up to 20% difference in the surface calculated from their respective adsorption. Methylene blue is a cation; both pore size and charge effects may influence its adsorption. Pharmaceutical analysis was done by Technologiezentrum Wasser (TZW) using LC/MS/MS. The analysis method is described in (Sacher et al. 2001) . The limit of quantification of this method was 0.02 mg/L for all pharmaceuticals when 2 L of sample volume was used. The accuracy of measured concentrations was estimated to be þ /À20% by TZW, indicating a higher accuracy when low concentrations are measured, i.e., when pharmaceuticals are adsorbed effectively. This yields the error margins shown in Table 2 .
RESULTS AND DISCUSSION

Water quality
Total carbon concentrations were similar for both water types (Table 3) . However, in waste water higher levels of hydrophobic organic carbon were detected. Five NOM size-fractions were obtained from LC-OCD analyses, and humic substances represented the largest fraction. Wastewater contained higher concentrations of the large biopolymers. Concentrations of NOM fractions with similar molecular weight as the pharmaceuticals (neutrals, acids) were higher in wastewater (0.96 mg/L) than in surface water (0.69 mg/L). The average molecular weight of humic substances in wastewater was lower than that of the surface water. This indicates that wastewater has a higher potential for direct adsorption competition than surface water.
GAC characterisation
All GAC samples were dried before use. For preloaded GAC, drying changes the characteristics of the NOM adsorbed onto the surface (Gorham et al. 2007) , forming larger, ring-shaped aggregates. As such, the pore volume distribution measured here may vary from the actual situation.
It was observed that the total pore volume of fresh GAC 830P mainly consists of pores o1 nm (50%) and to a lesser degree of pores in the ranges 1-25 nm and 425 nm (20% and 30%, respectively) (see Table 4 ).
The BET surface area of surface water (SW) preloaded GAC and wastewater (WW) preloaded GAC is similar, and yields a reduction of 24-28% with respect to virgin GAC. Error margin 20-15% 15-11% 11-8% 8-4% 4-0% SW preloaded GAC appears to have slightly less accessible surface area based on BET surface area measurements, and this is confirmed by the iodine number. This can be related to the larger fraction of medium-sized humic substances in surface water, which had a larger average size than those in waste water. Methylene blue (MB) adsorption was slightly lower on wastewater preloaded GAC. As wastewater contains higher concentrations of large biopolymers (MW420,000 g/mol), this might be related to partial pore blocking of the pore amount by these molecules, blocking pore access for methylene blue, but not for iodine or nitrogen. However, the differences in methylene blue adsorption can also be related to differences in surface charge.
The mesopore volume measured on surface water preloaded GAC was unrealistic, as the measured volume exceeded that of fresh GAC. This cannot be explained by the narrowing of macro pores, as the macro pore volume remained unchanged.
Effect of GAC preloading and water quality on equilibrium removal
The pH levels of the surface water and wastewater were 8.1 and 7.4, respectively. This variation of pH will have limited effect on the charge of the pharmaceuticals. Negatively charged solutes are fully dissociated at both pH values. Of the positively charged solutes, terbutaline (pK a 8.8) is protonated for 83% at pH 8.1. Protonation of the other pharmaceuticals and protonation at pH 7.4 are higher.
The point of zero charge was not determined for the fresh GAC, but lies typically between 7 and 8 (Bjelopavlic et al. 1999) . In this range, the surface charge of fresh GAC is expected to be slightly negatively charged at pH 8.1, and neutral or slightly positively charged at pH 7.4. Preloaded GAC obtains a significant negative surface charge (Newcombe 1994) . As such, charge interactions are expected to be limited on fresh GAC, and significant on preloaded GAC. Hydrophobic interaction is expected to be more significant for negatively charged solutes than for neutral or positively charged solutes, based on log D values.
Surface water experiments
In ultrapure water and using freshly regenerated GAC, most solutes were removed at more than 85% at even the lowest GAC dose (Figure 1) . When GAC was preloaded with either surface water, a strong decrease in removal of negatively charged solutes was observed, while for positively charged solutes removal was barely affected. This can be explained by the negative surface charge that the GAC surface obtained due to NOM preloading, which resulted in the attraction of positively charged solutes and repulsion of the negatively charged solutes.
Within the charged groups, more hydrophobic solutes (higher log D) generally showed higher removal. However, log D only partially explained differences within a charge group; the neutral carbamazepine and the negatively charged diclofenac and gemfibrozil showed lower removal than expected based on their log D values. The lower removal of carbamazepine might be related to its bulkier shape, with a cross section of approximately 5.8 Å. This may prevent access to (partially blocked) pores which are accessible to other solutes. No explanation was found for the relatively low removal of diclofenac and gemfibrozil. Despite the low log D values of positively charged solutes, their removal was higher than neutral and negatively charged solutes, demonstrating the relevance of charge interactions. In surface water, using freshly regenerated GAC, charge interactions were limited; negatively charged solutes showed only slightly lower removal than neutral solutes, which showed only slightly lower removal than positively charged solutes. This can be related to the lower surface charge of fresh GAC and to charge shielding by ions. Except for clofibric acid, ibuprofen, and cyclophosphamide, all solutes within charge groups showed similar removal. In surface water using preloaded GAC, charge interactions were important. However, they were lower than when using ultrapure water due to charge shielding effects by ions present in natural water. Removal was reduced for positively charged solutes (up to 30%) and increased for negatively charged solutes (up to 18%).
Wastewater experiments
In blank wastewater samples (GAC dose 0 mg/L), five pharmaceuticals were present in low concentrations after an equilibrium time of 8 weeks. This can be caused by binding with the NOM present in the water phase during the experiment, or by interference of NOM with the solid phase extraction (SPE) concentration step in the analysis. These solutes were excluded in Figure 2 .
In ultrapure water, pharmaceuticals were removed less effectively on wastewater preloaded GAC than with surface water preloaded GAC, with a typical reduction of removal of 10-50% for charged and neutral pharmaceuticals at a GAC concentration of 6.7 mg/L. This reduction cannot be attributed to differences in pore blocking, as Table 4 indicates that pore blocking is even lower on wastewater preloaded GAC as compared with surface water preloaded GAC. Based on SUVA and HOC fractions from the LC-OCD analysis, wastewater NOM is more hydrophobic then surface water NOM. As a consequence, competition of pharmaceuticals with NOM is higher for wastewater preloaded NOM than for surface water preloaded NOM. This indicates that the hydrophobicity of the preloaded NOM has a greater effect on pharmaceutical removal than does pore blocking.
CONCLUSIONS
The influence of NOM competition and pore blocking could not be separated. With respect to virgin carbon, the reduction of available surface area is similar for both preloaded carbons 9 Pharmaceutical equilibrium removal on 6.7-88.9 mg/L fresh or preloaded GAC in ultrapure water and treated surface water.
(24-28% reduction), with a slightly lower reduction of surface area for wastewater preloaded GAC. Wastewater NOM contained fractions with smaller molecular weight and higher SUVA then surface water NOM, indicating a higher potential for adsorption competition. When comparing pharmaceutical removal on wastewater preloaded GAC and surface water preloaded GAC, 10-50% lower pharmaceutical removal was observed for wastewater preloaded GAC at a GAC dose of 6.7 mg/L. This effect was related to higher competition with wastewater NOM, and may indicate that NOM competition influences pharmaceutical removal more than pore blocking under the experimental conditions applied in this paper. More variations in GAC type and natural water type are needed to generalise this finding.
Log D and charge interaction both had significant influence on pharmaceutical removal and should be considered when constructing a-priori prediction models. Preloaded GAC obtains a negative surface charge as a consequence of accumulation of NOM on its surface. The negatively charged pharmaceuticals had higher log D values than positively charged pharmaceuticals (0.57 to 2.77 versus À1.7-1.48, respectively). When only hydrophobic interactions are con-sidered, higher removal of negatively charged solutes is expected. However, considerably higher removal of positively charged solutes was observed on preloaded carbon compared to removal of negatively charged solutes (32-98% removal vs 0-58% removal, respectively, at 6.7 mg/L GAC). This indicates that charge interactions are a dominant removal mechanism on preloaded carbon.
Within a charge group, pharmaceuticals with higher log D values showed higher removal. Charge shielding by ions in natural water could reduce the influence of charge interaction, increasing removal of negatively charged solutes by up to 18% and reducing removal of positively charged solutes by up to 30%.
